Jefferies Starts Altimmune (ALT) at Buy, Sees 100%+ Upside
Tweet Send to a Friend
(Updated - December 14, 2020 7:59 AM EST)(updated to add analyst comments)Jefferies analyst Kelechi Chikere initiates coverage on Altimmune (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


